Quinoline derivatives were introduced way back in 1960s
Materials and Methods for the treatment of amoebic dysentery in man. The use of an oxyquinoline derivative iodochlorhydroxyquinoline was banned since prolonged usage caused a neurological syndrome subacute myelo-optic neuropathy (SMON) in Japanese people. However, recently evidence has accumulated to suggest that metal chelator iodochlorhydroxyquinoline has its potential usage in control of oxidative damage in parkinson's, alzheimer's, amylotrophic lateral sclerosis and other neurodegenerative diseases. [1] Halquinol, a related drug having antibacterial, antifungal and antiprotozoal activity is still being used in India to overcome common challenges of modern poultry and swine farming like microbial infections and growth promotion aspects. Neurotoxicity is reported with halquinol. [2] However, the details of toxicity of halquinol are scanty. Hence the present study was undertaken to assess the organ directed toxicity of halquinol in a repeated dose 28-day oral toxicity study in female rats.
Halquinol is a mixture obtained by chlorinating quinolin-8-ol. It contains not less than 57 per cent and not more than 74 per cent of 5, 7-dichloroquinolin-8-ol, not less than 23 per cent and not more than 40 per cent of 5-chloroquinolin-8-ol and not more than 4 per cent of 7-chloroquinolin-8-ol and the total content of the three components is not less than 95 per cent and not more than 105 per cent. [3] The oxyquinoline derivative halquinol (HALQUINOL BP 80. 98% W/W, manufactured and supplied by M/s. Vetcare, Bangalore) was used in the present study. The study was conducted as per OECD test guidelines [4] for repeated dose 28-day Oral Toxicity Study in Rodents. Female wistar albino rats weighing 110-115g and aged between six to seven weeks were procured from the Laboratory Animal Facility of Veterinary College, Hebbal, Bangalore. After acclimatization for a week, animals were grouped into four groups and each group consisted of six rats. They were maintained under standard laboratory hygienic conditions, providing standard laboratory animal feed and water ad libitum. The approval of the Institutional Animal Ethics Committee was obtained prior to start of the experiment. Group I served as control. Halquinol suspended in tragacanth mucilage (BP 1973) was administered by oral gavage as a single dose using a stomach tube, at the dose of 150 mg/kg body weight (Low dose) to Group II, 450 mg/kg body weight (Mid dose) to Group III and 1000 mg/kg body weight (high dose) to Group IV daily for a period of 28 days. The doses were selected on the haematological parameters were determined following standard methods. [5] The biochemical parameters were analyzed using ARTOS Semi-Automatic Biochemical Analyzer. The commercially available diagnostic kits from M/s. Swemed diagnostics, Bangalore, were employed in the estimation of the above parameters. After overnight fasting, the rats were weighed and sacrificed on Day 28 under ether anesthesia and the necropsy was conducted on each carcass to note down gross pathological changes. Organs namely liver, kidney, heart, lung and spleen were collected and weighed carefully on an analytical balance and weight of each organ recorded. Organ to body weight ratio basis of acute toxicity study and limit test where the highest was calculated. The representative tissue samples were collected dose was chosen with the aim of inducing toxic effects but not in neutral buffered formalin and processed for histopathology death or severe suffering. Thereafter, a descending sequence by cutting sections of 5 micron thickness and staining with of dose level was selected with an aim to demonstrate a dose haematoxylin and eosin. [6] related response and no-observed adverse effects at the lowest The data was expressed as mean ± standard error of mean dose level (NOAEL). Each rat was weighed at the beginning (SEM). The data was analyzed statistically by One-way ANOVA of the study and at weekly intervals thereafter till the end of followed by Dunnett's post test using GraphPad Prism software, the study. Exposure to halquinol in poultry and swine farming version 4.01. [7] depends on the stage of life. Halquinol to weaning piglets and Results growers is given at the rate of 30-60 g/ tonne of feed whereas to finishers it is 30 g/tonne of feed. For chronic scouring, halquinol
The observed clinical signs of toxicity in the present study is used at the rate of 600 g/tonne of feed for up to 7 days. In were burrowing behavior soon after administration of halquinol broilers, it is mixed in the feed at the concentrations of 30-60 in intermediate and high dose group. The high dose group showed g/tonne and in layers from 9 to 16 weeks of age halquinol is gradual loss of body weight and initiation of diarrhoea after day given at the rate of 30 g/tonne of feed and 30-60 g/tonne of 14. Day 20 onwards-severe diarrhoea, yellow urine, malena, feed in the later laying cycle.
dullness, depression, emaciation and hind leg weakness resulting General observations were made at least twice daily for in altered gait were observed. The above clinical signs were not signs of toxicity. Blood samples were collected by puncturing the evident in other groups given lower doses except mild diarrhoea retro orbital plexus using microhaematocrit capillary tubes on in the intermediate dose group after 20 th day of administration Day 0, 14 and 28 and subjected for analysis of haematological of halquinol. The body weight in the Group III and Group IV was parameters viz, haemoglobin (Hb), haematocrit (Hct), total significantly (P<0.01) lower than the control group value [Table erythrocyte count (TEC), mean corpuscular volume (MCV), mean 1]. The Hb, TEC and MCHC in Group IV was significantly (P<0.01) corpuscular haemoglobin (MCH), mean corpuscular haemoglobin lower than the control group value whereas the MCV in Group IV concentration (MCHC), total leukocyte count (TLC) and differential was significantly (P<0.01) higher than the control group value leukocyte count (DLC) and serum biochemical parameters viz, [ Table 2 ]. There was no significant (P>0.05) increase in Hct, MCH, alkaline phosphatase (ALP), alanine aminotransferase (ALT), TLC and DLC values in all the groups administered halquinol aspartate aminotransferase (AST), total serum protein (TSP), when compared to control. There was also significant (P<0.01) total albumin (TA), blood urea nitrogen (BUN) and creatinine increase in ALT, ALP, BUN and creatinine concentration in Group (Creat). Disodium EDTA was used as an anticoagulant and the III and Group IV [ Table 3 ] but there was no significant (P>0.05) increase in AST, TSP and TA concentration. There was significant (P<0.01) increase in liver to body weight ratio and kidney to body weight ratio in Group III and Group IV [ Table 4 ]. At autopsy, rats in Group III and Group IV showed generalized paleness of mucous membranes and all visceral organs. Animals of the treated groups did not show any gross pathological lesions in any of the organs except for catarrhal enteritis in Group III and Group IV. Microscopically liver from rats of high dose group showed congestion of sinusoidal spaces, hydropic degeneration with granular eosinophilic cytoplasm of hepatocytes and multiple areas of necrosis [ Figure 1 ]. The lesions in kidney microscopically were cystic dilatation of collecting tubules lined by flattened epithelial cells and necrosis of lining epithelium of the kidney tubules. Some renal tubules showed vacuolar degeneration and necrosis of the lining epithelial cells [ Figures 2 and 3] . Kidney tubules also showed retention of urine. Microscopically intestines revealed mainly catarrhal inflammation characterized by degeneration and necrosis of tips of intestinal villi, increased goblet cell activity, mild haemorrhage and infiltration of inflammatory cells in lamina propria and widening of lymphoid component in large intestine. Histopathology of rats from intermediate dose group The body weight of high dose and intermediate dose group was significantly (P<0.01) lower than the control group value. Low dose group showed normal weight gains and exhibited no toxic effects. This finding is similar to the finding reported by Heseltine and Campbell, [8] who reported normal weight gains with no toxic effects in male and female rats given halquinol orally at doses of 0.2 g/kg daily for 14 days and 0.6 g/kg daily of clioquinol in five dogs. The Hb, TEC and MCHC decreased significantly (P<0.01) whereas MCV increased significantly (P<0.01) in high dose group. The present findings of reduced erythrocyte counts and haemoglobin concentrations are in agreement to Hoover and Carlton, [10] who reported reduced erythrocyte counts and haemoglobin concentrations in Beagle dogs treated with clioquinol for a period of 100 days. The observed fall in haemoglobin concentrations and erythrocyte counts in high dose group might have occurred because of acute loss of blood through faeces (melena). This correlated with the gross pathological change of generalized paleness of all mucous membranes and visceral organs of the body. The observed increase in MCV and decrease in MCHC is suggestive of macrocytic hypochromic anaemia which might have occurred Table 4 Effect of Halquinol on organ to body weight ratio (%)in female rats in 28 day oral toxicity study because of acute loss of blood through faeces (melena). due to diarrhea and dehydration. Similar increase in relative High and intermediate dose exerted toxic effect on the kidney weight due to cystic dilatation and retention of urine liver and the toxic effect on high dose group was more severe was observed in newborn rats with partial unilateral ureteric compared to that of intermediate dose group, which correlated obstruction. [13] well with the histopathologic lesions in liver and increase in Thus from the present study it was concluded that halquinol biochemical parameters ALT and ALP. Halquinol at high dose at high and intermediate dose is hepatotoxic and nephrotoxic and intermediate dose also has toxic effect on the kidney. The in female rats. toxic effect in high dose group is more severe compared to
